G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells

Experimental Hematology

Volumn 34, Issue 8, 2006, Pages 1060-1068

  Christopherson II, Kent W ^a   Uralil, Sherene E ^a   Porecha, Nehal K ^a   Zabriskie, Ryan C ^a   Kidd, Shannon M ^a   Ramin, Susan M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; DIPROTIN A; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL POPULATION; CHEMOTAXIS; CONTROLLED STUDY; DOWN REGULATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; UPREGULATION;

ANTIGENS, CD26; ANTIGENS, CD34; ANTIGENS, CD38; CHEMOKINES, CXC; CHEMOTAXIS; FETAL BLOOD; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; UP-REGULATION;

EID: 33746086688     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.03.012     Document Type: Article

References (45)

1. Juttner C.A., To L.B., Haylock D.N., Branford A., and Kimber R.J. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Haematol 61 (1985) 739-745
2. Reiffers J., Bernard P., David B., et al. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol 14 (1986) 312-315
3. To L.B., Roberts M.M., Haylock D.N., et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9 (1992) 277-284
4. Duhrsen U., Villeval J.L., Boyd J., Kannourakis G., Morstyn G., and Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72 (1988) 2074-2081
5. Socinski M.A., Cannistra S.A., Elias A., Antman K.H., Schnipper L., and Griffin J.D. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1 (1988) 1194-1198
6. Molineux G., Migdalska A., Szmitkowski M., Zsebo K., and Dexter T.M. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78 (1991) 961-966
7. Brasel K., McKenna H.J., Morrissey P.J., et al. Hematologic effects of flt3 ligand in vivo in mice. Blood 88 (1996) 2004-2012
8. Orazi A., Cattoretti G., Schiro R., et al. Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow. Blood 79 (1992) 2610-2619
9. Appelbaum F.R. Allogeneic marrow transplantation and the use of hematopoietic growth factors. Stem Cells 13 (1995) 344-350
10. Rutella S., Rumi C., Sica S., and Leone G. Recombinant human granulocyte colony-stimulating factor (rHuG-CSF): effects on lymphocyte phenotype and function. J Interferon Cytokine Res 19 (1999) 989-994
11. De Witte T., Gratwohl A., Van Der Lely N., et al. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation. Blood 79 (1992) 1359-1365
12. Masaoka T., Takaku F., Kato S., et al. Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. Exp Hematol 17 (1989) 1047-1050
13. Rosenfeld C., Collins R., Pineiro L., Agura E., and Nemunaitis J. Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study. J Clin Oncol 14 (1996) 1314-1319
14. Bensinger W.I., Longin K., Appelbaum F., et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87 (1994) 825-831
15. Martin-Algarra S., Bishop M.R., Tarantolo S., et al. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs-host disease prophylaxis. Exp Hematol 23 (1995) 1503-1508
16. Khoury H.J., Loberiza Jr. F.R., Ringden O., et al. Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. Blood 107 (2006) 1712-1716
17. Broxmeyer H.E., Douglas G.W., Hangoc G., et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 86 (1989) 3828-3832
18. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321 (1989) 1174-1178
19. Wagner J.E. Umbilical cord blood transplantation: overview of the clinical experience. Blood Cells 20 (1994) 227-233
20. Wagner J.E., Kernan N.A., Steinbuch M., Broxmeyer H.E., and Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 346 (1995) 214-219
21. Shpall E.J., Quinones R., Giller R., et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 8 (2002) 368-376
22. + cord blood cells. Blood 93 (1999) 1097-1105
23. + cells. Transfusion 41 (2001) 213
24. + mobilized peripheral blood stem cells. Blood 91 (1998) 111-117
25. McNiece I., Harrington J., Turney J., Kellner J., and Shpall E.J. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 6 (2004) 311-317
26. Lemischka I.R., and Moore K.A. Stem cells: interactive niches. Nature 425 (2003) 778-779
27. Fuchs E., Tumbar T., and Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 116 (2004) 769-778
28. Bongers J., Lambros T., Ahmad M., and Heimer E.P. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs. Biochim Biophys Acta 1122 (1992) 147-153
29. Lambeir A.M., Proost P., Durinx C., et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem 276 (2001) 29839-29845
30. + progenitors to peripheral blood. J Exp Med 185 (1997) 111-120
31. Christopherson K.W., and Broxmeyer H.E. Hematopoietic stem and progenitor cell homing, engraftment, and mobilization in the context of the CXCL12/SDF-1-CXCR4 axis. In: Broxmeyer H.E. (Ed). Cord Blood: Biology, Immunology, Banking, and Clinical Transplantation (2004), AABB Press, Bethesda, MD 65-86
32. Peled A., Petit I., Kollet O., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283 (1999) 845-848
33. Petit I., Szyper-Kravitz M., Nagler A., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3 (2002) 687-694
34. Cashman J., Clark-Lewis I., Eaves A., and Eaves C. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. Blood 99 (2002) 792-799
35. + cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 95 (2000) 756-768
36. Broxmeyer H.E., Kohli L., Kim C.H., et al. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gαi proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol 73 (2003) 630-638
37. Crump M.P., Gong J.H., Loetscher P., et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 16 (1997) 6996-7007
38. + progenitor cells. J Immunol 169 (2002) 7000-7008
39. Christopherson II K.W., Cooper S., and Broxmeyer H.E. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 101 (2003) 4680-4686
40. -/- mice. Exp Hematol 31 (2003) 1126-1134
41. Christopherson II K.W., Hangoc G., Mantel C.R., and Broxmeyer H.E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305 (2004) 1000-1003
42. Tian C., Bagley J., Forman D., and Iacomini J. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther 13 (2006) 652-658
43. -ΔΔC(T) method. Methods 25 (2001) 402-408
44. Bogenrieder T., Finstad C.L., Freeman R.H., et al. Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate 33 (1997) 225-232
45. Wilson M.J., Ruhland A.R., Pryor J.L., et al. Prostate specific origin of dipeptidylpeptidase IV (CD-26) in human seminal plasma. J Urol 160 (1998) 1905-1909